Inflammation, Depression and Dementia: Are they Connected?
Tóm tắt
Từ khóa
Tài liệu tham khảo
Leonard BE (1989) The amine hypothesis of depression: a reassessment. In: TiptonK F, Youdim MBH (eds) Biochemical and pharmacological aspects of depression. Taylor and Francis, London, pp 25–49
Brambilla F (2000) Psychoneuroendocriniligy: research on the pituitary-adrenal-cortical system. Psychosomat Med 62:576–607
Jonas BS, Laudo JF (2000) Negative affect as a prospective risk factor of hypertension. Psychosomat Med 62:188–196
Leonard BE (2006) Physical consequences of depression. Quart J mental Health 1:33–38
Maes M (1999) Major depression and activation of the inflammatory response. Adv Exp Biol Med 461:25–46
Evans DL (2005) Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiat 58:175–189
Geerlings MI, Schoevers RA, Beckman AT et al (2000) Depression and risk of cognitive decline and Alzheimer’s disease. Results of 2 prospective community based studies in the Netherlands. Br J Psychiat 176:568–575
Steffens DC, Plassman BL, Helms MJ et al (1997) A twin study of late onset depression and apolipoprotein E4 as risk factors for Alzheimer’s disease. Biol Psychiat 41:851–856
Song C, Dinan TG, Leonard BE (1994) Changes in immunoglobulins, complement and acute phase proteins in depressed patients and normal controls. J Affect Dis 30:283–288
Ford DE, Erlinger TP (2004) Depression and C-reactive protein in U.S. adults. Arch Intern Med 164:1010–1014
Lanquillon S (2000) Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 22:370–379
Levine J (2000) Cerebrospinal cytokine levels in patients with acute depression. Neuropsychobiology 40:171–176
Yu YW (2003) Association study of the IL-1 beta (C-511T) genetic polymorphism with major depressive disorder, associated symptomatology and antidepressant response. Neuropsychopharmacology 28:1182–1185
Jun TY (2003) Possible association between -G308A TNF alpha gene polymorphism and major depressive disorder in a Korean population. Psychiat Genet 13:179–181
Suarez EC (2004) Enhanced expression of cytokines and chemokines by blood monocytes to in vitro lipopolysaccharide stimulation is associated with hostility and severity of depressive symptoms in healthy women. Psychoneuroendocrinology 29:1119–1128
van der Ven A (2003) Herpes viruses,cytokines and altered haemostsis in vital exhaustion. Psychosomat Med 65:194–200
Leonard BE, Song C (2007) Stress, the immune system and depression. In: Encyclopedia of stress. Elsevier North Holland Press. (in press)
Haack M (1999) Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and depression. J Pdsychiat Res 33:407–418
Steptoe A (2003) Lack of association between depressive symptoms and markers of immune and vascular inflammation in middle aged men and women. Psychol Med 33:667–674
Miller GE (2003) Pathways linking depression, adiposity and inflammatory markers in healthy young adults. Brain Behav Immun 17:276–285
Owen BM (2001) Raised levels of plasma IL-1 beta in major and post viral depression. Acta Psychiat Scand 103:226–228
Sluzewska A, Rybakowski J, Bosmans E. et al (1996) Indicators of immune activation in major depression. Psychiat Res 64:162–167
Myint A-M, Leonard BE, Steinbusch HW, Kim Y-K (2005) Thi, Th2 and Th3 cytokine alteratikons in major depression. J Affect Dis 88:169–173
Wichers MC,Koek GH,Robaeys G et al (2005) IDO and interferon alpha induced`depressive symptoms: a shift in hypothesis from tryptophan depletion. Mol Psychiat 10:538–544
Meyers CA, Valentine AD (1995) Neurologic and psychiatric adverse effects of immunological therapy. CNS Drugs 3:56–68
Minden SL, Schiffer RB (1990) Affective disorder in multiple sclerosis. Gen Hosp Psychiatry 9:426–434
Marshall PS (1993) Allergy and depression: a neurochemical threshold model of the relation between the illnesses. Psychol Bull 113:23–43
Katon W, Sullivan MD (1990) Depression and chronic medical illness. J Clin Psychiatry 51:3–11
Schrott LM, Crnic LS (1996) Anxiety behavior, exploratory behavior and activitZBx and NZB F1 hybrid mice: role of genotype and autoimmune disease progression. Brain Behav Immun 10:260–274
Myint A-M, Kim Y-K (2003) Cytokine-serotonin interactions through indoleamine 2,3-dioxygenase: a neurodegenerative hypothesis of depression. Med Hypoth 61:519–525
Capuron L (2002) Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoin cytokine therapy. Mol Psychiat 7:468–473
Capuron L (2003) Association of exaggerated HPA axis response to the initial injection of IFN alpha with development of depression during IFN alpha therapy. Am J Psychiat 160:1342–1345
Juenling FD (2000) Prefrontal cortical hypometabolism during low dose IFN alpha treatment. Psychopharmacology 152:383–389
Capuron L (2005) Anterior cingulate activation and error processing during IFN alpha treatment. Biol Psychiatry 58:190–196
Selkoe DJ (2004) Alzheimer’s disease: mechanistic understanding predictors novel therapies. Ann Intern Med 140:627–638
Hewett SJ, Csernansky CA, Choi DW (1994) Selective potentiation of NMDA induced neural injury following induction of astrocytic iNOS. Neuron 13:487–494
Song C, Horrobin DF, Leonard BE (2006) The comparison of changes in behaviour, neurochemistry, endocrine and immune functions after different routes, doses and durations of administration of IL-1 beta in rats. Pharmacopsychiatry 39:88–99
Herx LM, Rivest S, Young VW (2000) CNS initiated inflammation and neurotrophism in trauma: IL-1 beta is required for the production of ciliary neurotrophic factor. J Immunol 165:2232–2239
Strjbos P, Rothwell N (1995) IL-1 beta attenuates excitatory amino acid neurodegeneration in vitro: involement of NGF. J Neurosci 15:3468–3474
Vandenabecle P, Fiers W (1991) Is amyloidogenesis during Alzheimer’s disease due to an IL-1/IL-6 mediated acute phase reaction in the brain? Immunol Today 12:217–219
Grimaldi LM, Casadrei VM, Ferri C et al (2000) Association of early onset Alzheimer’s disease with IL-1 alpha gene polymorphism. Ann Neurol 47:361–365
Meda L, Cassatella MA, Szendrei GI et al (1995) Activation of microglial cells bt beta amyloid protein and IFN gamma. Nature 374:647–650
Sciacca FL, Ferri C, Licastro F et al (2003) IL-1beta polymorphism is associated with age at onset of Alzheimer’s disease. Neurobiol Aging 24:927–931
Norris JG, Benveniste EN (1993) IL-6 production by astrocytes: induction by norepinephrine. J Neuroimmunol 45:137–145
Ye SM, Johnson RW (1999) Increased IL-6 expression by microglia from brain of aged mice. J Neuroimmunol 93:139–148
Gradient RA, Otten V (1993) Differential expression of IL-6 and IL-6 receptor on RNA’s in rat hypothalamus. Neurosci Lett 153:13–16
Qui Z, Sweeney DD, Netzeband JG, Grud DL (1998) Chronic IL-6 alters NMDA receptor mediated membrane responses and enhances neurotoxicity in developing CNS neurons. J Neurosci 18:10445–10456
Tarkowski E, Blennow K, Wallin A, Tarkowski A (1999) Intracerebral production of TNF alpha, a local neuroprotective agent, in Alzheimer’s disease and vascular dementia. J Clin Immunol 19:223–230
Lanzem AS, Johnston CM, Perry VH et al (1998) Longitudinal study of inflammatory factors in serum, CSF and brain tissue in Alzheimer’s disease: IL-1 beta, IL-6,IL-1 receptor antagonist, TNF alpha, soluble TNF receptors and alpha-chymotrypsin. Alzheim Dis Assoc Disord 12:215–227
Knezevic-Cuca J, Stansberry KB, Johnston G et al (2000) Neurotrophic role of IL-6 and soluble IL-6 receptor in NIE-115 neuroblastoma cells. J Neuroimmunol 102:8–16
Blasko I, Marx F, Steiner E et al (1999) TNF alpha plus IFN gamma induce production oif Alzheimer beta amyloid peptides and decrease secretion of amyloid precursor proteins. FASEB J 13:63–68
McCusker SM, Curran MD, Dynan KB et al (2001) Association between polymorphism in regulating region of gene encoding TNF alpha and risk of Alzheimer’s disease and vascular dementia: a case controlled study. Lancet 357:436–439
Infante J, Llorca J, Berciano J, Combarros O (2002) No synergistic effect between 850 TNF alpha promoter polymorphism and APOE epsilon 4 allele in Alzheimer’s disease. Neurosci Lett 328:71–73
Mitrasinovic OM, Perez GV, Zhao F et al (2001) Overexpression of macrophage colony stimulating factor receptor on microglial cells induces an inflammatory response. J biol Chem 276:30142–30149
Finch CE, Laping NJ, Morgan TE et al (1993) TGF beta 1 is an organiser of responses to neurodegeneration. J cell Biochem 53:314–322
Flanders KC, Ren RF, Lippa VCF (1998) TGF betas in neurodegenerative disease. Prog Neurobiol Biol Psychiatry 54:71–85
Kanne SM, Balota DA, Storandt M et al (1998) Relating anatomy to function in Alzheimer’s disease: neuropsychological profiles predict regional neuropathology 5 years later. Neurol 50:979–985
Lyketos CG, Olin J (2002) Depression in Alzheimer’s disease: overview and treatment. Biol Psychiatry 52:243–252
Rapp MA, Dahlman K, Sano M et al (2005) Neuropsychological differences between late onset and recurrent geriatric major depression. Am J Psychiatry 162:691–698
Guillemin GJ, Kerr SJ, Smythe GA et al (2001) The kynurenine pathway metabolism in human astrocytes: pathway for neuroprotection. J Neurochem 78:842–853
Hayaishi O Biochemical and medical aspects of tryptophan metabolism Elsevier: Amsterdam/North Holland Biomed (Press)
Stone TW, Darlington LG (2002) Endogenous kynurenines as targets for drug discovery and development. Nat Rev Drug Discov 1:609–620
Heyes MP, Achim CL, Wiley CA et al (1996) Human microglia convert l-tryptophan into neurotoxic quiolinic acid. Biochem J 320(pt.2):595–597
Butterfield DA, Casegna A, Lauderback CM, Drake J (2002) Evidence that amyloid beta peptide induced lipid peroxidation and its sequelae in Alzheimer’s brain contribute to neural death. Neurobiol Aging 23:655–664
Heyes MP, Saito K, Major EO et al (1993) A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Brain 16:1425–1450
Markesberry WR (1997) Oxidative stress hypothesis in Alzheimer’s disease. Free Radic Biol Med 23:134–147
Hartai Z, Juhasz A, Rimanoczy A et al Decreased serum and red blood cell kynurenic acid levels in Alzheimer’s disease.Neurochem.Int.doi:10.1016/j.neuint.2006.08.012
Leonard BE, Myint A-M (2006) Inflammation and depression: is there a causal connection with dementia? Neurotox Res 10:149–160
Vythingham M (2002) Childhood trauma associated with smaller hippocampal volume in women with major depression. Am J Psychiat 159:2072–2080
Malberg JE, Eisch AJ, Nessler EJ, Duman RS (2000) Chronic antidepressant treatment imcreases neurogenesis in adult rat hippocampus. J Neurosci 20:9104–9110
Santarelli L (2003) Requirement of hippocampal neurogenesis for the behavioural effects of antidepressants. Science 301:805–809
Saivanen M, Lucas G, Emfors P et al (2005) BDNF and antidepressants have different but co-ordinated effects on neural turnoiver, proliferation and survival in the adult dendate gyrus. J Neurosci 25:1089–1094
Nibuya M, Takahashi M, Russell DS, Duman RS (1999) Chronic stress increases catalytic TrkB mRNA in rat hippocampus. Neurosci Lett 267:81–84
Vaidya VA, Siuciak JA, Du F, Duman RS (1999) Hippocampal mossy fibre sprouting induced by chronic ECS. Neurosci 898:157–166
Fujioka T, Fujioka A, Duman RS (2004) Activation of cAMP signalling facilitates the morphological maturation of new born neurons in adult hippocampus. J Neurosci 24:319–328